SS Innovations International, Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes excellence in innovation, commercial success, industry leadership and positive societal impact. The award underscores the company's growing footprint in the surgical robotics field, driven by its SSi Mantra surgical robotic system.
According to the company, the SSi Mantra system has gained traction for its advanced technology, user-friendly design, training capabilities and cost efficiency. As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The company also said approximately 2,100 physicians have been trained on the platform, which has been used for more than 170 procedure types and has received regulatory approval in 14 countries.
The award and the growing number of procedures signal that SS Innovations is making strides in its mission to make robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes the SSi Mantra system and its suite of SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery.
The recognition is significant for the industry as it highlights the increasing role of cost-effective robotic solutions in expanding access to minimally invasive surgery. With the SSi Mantra system now approved in 14 countries and used for over 170 procedure types, the potential impact on global healthcare is substantial, particularly in regions where high-cost robotic systems have been a barrier to adoption.
For more information, visit the full press release at https://ibn.fm/XWdRe and the company's website at ssinnovations.com.
